(C) BoingBoing
Author Name: BoingBoing
This story was originally published on Boingboing.net. [1]
License: CC-BY-NC-SA 3.0.[2]


Psilocybin is an effective treatment against depression in largest-ever randomized trial

2021-11-10 00:00:00

A drug trial with 233 patients in Europe and North America revealed promising results for psilocybin as a treatment for depression. The test was undertaken by Compass Pathways a mental health care company.

From Stat:

The Phase 2b study is the largest randomized, controlled, double-blind trial of psilocybin, the psychedelic compound in magic mushrooms. The company said it found that patients who were given the highest dose, 25 milligrams, had a significant decrease in depressive symptoms compared to those given 1 milligram, which is such a low dose it functions as a placebo.

Overall, 29.1% of patients in the highest-dose group were in remission three weeks after treatment, compared to 7.6% of those in the control group, and more than a quarter of the patients in the 25-milligram arm were still in remission three months after treatment.
[END]

[1] URL: https://boingboing.net/2021/11/10/psilocybin-is-an-effective-treatment-against-depression-in-largest-ever-randomized-trial.html
[2] URL: https://creativecommons.org/licenses/by-nc-sa/3.0/us/

BoingBoing via Magical.Fish Gopher News Feeds:
gopher://magical.fish/1/feeds/news/rferl/

You are viewing proxied material from magical.fish. The copyright of proxied material belongs to its original authors. Any comments or complaints in relation to proxied material should be directed to the original authors of the content concerned. Please see the disclaimer for more details.